Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 410 followers
Latest posts
Last updated about 8 hours ago
FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
about 8 hours ago
Approval of the first-in-class norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) gives the...
On 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD
about 9 hours ago
Roche’s cancer treatment Avastin has long been employed as an off-label option...
Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chapter
about 9 hours ago
Some five months after announcing the planned retirement of its longtime CEO...
Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chaper
about 9 hours ago
Some five months after announcing the planned retirement of its longtime CEO...
AZ stays on track for $80B revenue goal as cancer meds help offset Ultomiris miss
about 10 hours ago
Even as trial setbacks and pipeline adjustment rear their heads, AstraZeneca feels...
Legend Biotech CEO abruptly steps down without permanent replacement
about 11 hours ago
In a sudden leadership shift, Legend Biotech announced that its CEO Ying...
Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
3 days ago
A survey of 36 U.S. gastroenterologists found that significant treatment gaps remain...
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
3 days ago
As outside experts gathered for a second day to discuss adding certain...
Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
3 days ago
The company is targeting Lilly ad campaigns that cite what Novo calls...
Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial
3 days ago
Three years after gaining three liver disease assets in its $952 million...
Amgen hands in data package in hopes of FDA hearing for Tavneos defense
3 days ago
With all eyes on Tavneos’ seemingly precarious approval status in the U.S...
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
3 days ago
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements...